| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.kwalitypharma.com | |
| Market Cap | 327.27 Cr. | |
| Enterprise Value(EV) | 394.18 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 115.64 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 2.73 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 32.18 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 199.55 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 1.58 | Calculated using Price: 315.40 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.04 Cr. | 10,376,198 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company ‘Kwality Pharmaceuticals Limited' was incorporated on May 04, 1983 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, H.P. and Chandigarh. It is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. It carries out its production through state-of-the-art manufacturing units situated at 6th Mile Stone, Village Nag Kalan, Majitha Road, Amritsar - 143006, Punjab, which is also its registered/administrative office and another manufacturing facility situated at 1-A Industrial Area, Raja ka bagh, Jassur, Himachal Pradesh. Both of its manufacturing facilities are well equipped and multiple products are manufactured at these facilities. Since incorporation, the company is ever progressing in Domestic and International market based on its commitment towards high quality and timely supplies. It provides specified and quality products for its customers while maintaining honesty, integrity and loyalty to its employees and customers. | ||
| 1 Day |
|
-0.38% |
| 1 Week |
|
-1.21% |
| 1 Month |
|
-6.17% |
| 3 Month |
|
-19.88% |
| 6 Month |
|
-26.81% |
| 1 Year |
|
-44.57% |
| 2 Year |
|
+542.36% |
| 5 Year |
|
+669.27% |
| 10 Year |
|
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 5.26 | 4.43 | 6.54 | 14.41 | 16.51 | 23.13 | 20.10 | 28.21 | 99.66 | |
| Return on Capital Employed (%) | 10.52 | 9.58 | 12.34 | 19.64 | 19.19 | 21.91 | 18.49 | 26.36 | 98.00 | |
| Return on Assets (%) | 2.66 | 2.21 | 2.90 | 5.37 | 5.29 | 7.50 | 6.90 | 9.97 | 47.33 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 18 | 19 | 22 | 26 | 30 | 37 | 46 | 61 | 181 | 201 | |
| Non Curr. Liab. | 2 | 1 | 3 | 4 | 5 | 8 | 20 | 28 | 31 | 26 | |
| Curr. Liab. | 15 | 17 | 27 | 42 | 62 | 61 | 68 | 78 | 130 | 114 | |
| Minority Int. | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Equity & Liab. | 35 | 37 | 51 | 71 | 96 | 105 | 132 | 166 | 341 | 339 | |
| Non Curr. Assets | 13 | 13 | 13 | 18 | 21 | 30 | 43 | 60 | 113 | 128 | |
| Curr. Assets | 22 | 24 | 38 | 53 | 75 | 75 | 89 | 106 | 228 | 210 | |
| Misc. Exp. not W/O | 0 | 0 | 0 | 0 | |||||||
| Total Assets | 35 | 37 | 51 | 71 | 96 | 105 | 132 | 166 | 341 | 339 |
| Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 60 | 52 | 74 | 98 | 137 | 166 | 139 | 262 | 456 | |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 2 | 4 | |
| Total Income | 60 | 53 | 75 | 100 | 138 | 167 | 143 | 264 | 460 | |
| Total Expenditure | -56 | -49 | -69 | -89 | -126 | -151 | -125 | -233 | -284 | |
| PBIDT | 4 | 4 | 5 | 10 | 12 | 16 | 18 | 30 | 175 | |
| Interest | -1 | -1 | -1 | -2 | -2 | -2 | -3 | -3 | -3 | |
| Depreciation | -1 | -1 | -2 | -3 | -3 | -3 | -4 | -6 | -11 | |
| Taxation | -1 | -1 | -1 | -2 | -3 | -3 | -3 | -6 | -42 | |
| Exceptional Items | ||||||||||
| PAT | 1 | 1 | 1 | 3 | 4 | 8 | 8 | 15 | 120 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Share Associate | ||||||||||
| Other Related Items | ||||||||||
| Consolidated Net Profit | 1 | 1 | 2 | 3 | 5 | 8 | 8 | 15 | 120 | |
| Adjusted EPS | 1 | 1 | 2 | 3 | 4 | 7 | 8 | 15 | 116 |
| Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -1 | 1 | -3 | 4 | -1 | 14 | 6 | 27 | 64 | |
| Cash Fr. Inv. | -3 | -1 | -2 | -7 | -6 | -12 | -18 | -23 | -63 | |
| Cash Fr. Finan. | 3 | 1 | 6 | 5 | 5 | -2 | 12 | 1 | 6 | |
| Net Change | -1 | 1 | 0 | 2 | -1 | 0 | 0 | 4 | 7 | |
| Cash & Cash Eqvt | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 6 | 13 |
|
Mon, 27 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ajay Kumar Arora & PACs |
|
Sat, 25 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ramesh Arora & PACs |
|
Sat, 18 Mar 2023
Announcement under Regulation 30 (LODR)-Change in Directorate Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that Mr. Neelmani Khemka (DIN: 09787109) Additional Director (Non-Executive and Independent) of the Company has tendered his resignation with effect from March 18 2023. The resignation letter will be taken on record at the ensuing Board Meeting of the Company.You are requested to please take on record the information as required to be disclosed by the Company pursuant to the Regulation 30(2) read with clause 7 and 7B of Para A Part A of Schedule III of SEBI (LODR) Regulations 2015 for change in Director. |
| Tue, 28 Mar 2023 |
High Delivery Percentage
|
High Decrease in 1 Month
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
High Decrease in 1 Year
|
Equities
M.F.
Sectors